Neurocrine Biosciences, Inc.
NBIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $233 | $251 | $263 | $341 |
| Short-Term Investments | $843 | $781 | $726 | $371 |
| Receivables | $479 | $439 | $350 | $186 |
| Inventory | $57 | $38 | $35 | $31 |
| Other Curr. Assets | $112 | $98 | $79 | $46 |
| Total Curr. Assets | $1,725 | $1,607 | $1,454 | $973 |
| Property Plant & Equip (Net) | $592 | $347 | $146 | $156 |
| Goodwill | $6 | $0 | $0 | $0 |
| Intangibles | $37 | $36 | $37 | $0 |
| Long-Term Investments | $864 | $849 | $402 | $624 |
| Tax Assets | $486 | $363 | $306 | $315 |
| Other NC Assets | $10 | $50 | $25 | $4 |
| Total NC Assets | $1,994 | $1,644 | $915 | $1,100 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,719 | $3,251 | $2,369 | $2,073 |
| Liabilities | – | – | – | – |
| Payables | $110 | $133 | $67 | $52 |
| Short-Term Debt | $0 | $170 | $169 | $0 |
| Tax Payable | $0 | $24 | $9 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $398 | $327 | $292 | $194 |
| Total Curr. Liab. | $508 | $655 | $538 | $246 |
| LT Debt | $455 | $258 | $94 | $440 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $166 | $106 | $30 | $12 |
| Total NC Liab. | $621 | $365 | $123 | $453 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $455 | $258 | $94 | $105 |
| Total Liabilities | $1,129 | $1,019 | $661 | $699 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $29 | -$157 | -$407 | -$636 |
| AOCI | $6 | $7 | -$8 | -$2 |
| Other Equity | $2,555 | $2,382 | $2,122 | $2,011 |
| Total Equity | $2,590 | $2,232 | $1,708 | $1,374 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,719 | $3,251 | $2,369 | $2,073 |
| Net Debt | $222 | $177 | $0 | $100 |